DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome

Fragile X syndrome (FXS) is a leading single-gene cause of intellectual disability (ID) with autism features. This study analysed diagnostic and prognostic utility of the Fragile X-Related Epigenetic Element 2 DNA methylation (FREE2m) assessed by Methylation Specific-Quantitative Melt Analysis and the EpiTYPER system, in retrospectively retrieved newborn blood spots (NBS) and newly created dried blood spots (DBS) from 65 children with FXS (~2–17 years). A further 168 NBS from infants from the general population were used to establish control reference ranges, in both sexes. FREE2m analysis showed sensitivity and specificity approaching 100%. In FXS males, NBS FREE2m strongly correlated with intellectual functioning and autism features, however associations were not as strong for FXS females. Fragile X mental retardation 1 gene (FMR1) mRNA levels in blood were correlated with FREE2m in both NBS and DBS, for both sexes. In females, DNAm was significantly increased at birth with a decrease in childhood. The findings support the use of FREE2m analysis in newborns for screening, diagnostic and prognostic testing in FXS.

[1]  S. Freeman.  Wechsler Preschool and Primary Scale of Intelligence , 2021, Encyclopedia of Autism Spectrum Disorders.

[2]  D. Wechsler.  Wechsler Intelligence Scale for Children , 2020, Definitions.

[3]  D. Amor,et al.  DNA methylation analysis for screening and diagnostic testing in neurodevelopmental disorders. , 2019, Essays in biochemistry.

[4]  D. Francis,et al.  Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing , 2019, Scientific Reports.

[5]  Jane E. Roberts,et al.  Developmental divergence: motor trajectories in children with fragile X syndrome with and without co-occurring autism , 2019, Journal of Neurodevelopmental Disorders.

[6]  D. Amor,et al.  Epigenetics of fragile X syndrome and fragile X‐related disorders , 2018, Developmental medicine and child neurology.

[7]  M. Fraga,et al.  Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes , 2019, Journal of Translational Medicine.

[8]  C. Dissanayake,et al.  Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X , 2018, Scientific Reports.

[9]  Hanxin Lin,et al.  Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes. , 2018, American journal of human genetics.

[10]  T. Peters,et al.  DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood , 2018, International Journal of Obesity.

[11]  Shannon E. Ellis,et al.  Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder , 2016, Nature Communications.

[12]  D. Lambrechts,et al.  Newborn genome-wide DNA methylation in association with pregnancy anxiety reveals a potential role for GABBR1 , 2017, Clinical Epigenetics.

[13]  M. Milá,et al.  Paternal transmission of a FMR1 full mutation allele , 2017, American journal of medical genetics. Part A.

[14]  W. Brown,et al.  Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment , 2017, Pediatrics.

[15]  A. Hamid,et al.  Epigenetic modifications at DMRs of placental genes are subjected to variations in normal gestation, pathological conditions and folate supplementation , 2017, Scientific Reports.

[16]  Tom R. Gaunt,et al.  DNA methylation and substance-use risk: a prospective, genome-wide study spanning gestation to adolescence , 2016, Translational psychiatry.

[17]  C. Wahlestedt,et al.  The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients. , 2016, Human molecular genetics.

[18]  Q. Bui,et al.  β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles , 2016, Scientific Reports.

[19]  Charles Auffray,et al.  DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis. , 2016, American journal of human genetics.

[20]  V. Faundes,et al.  Identification of Males with Cryptic Fragile X Alleles by Methylation-Specific Quantitative Melt Analysis. , 2016, Clinical chemistry.

[21]  Z. Stark,et al.  Prenatal diagnosis of fragile X syndrome complicated by full mutation retraction , 2015, American journal of medical genetics. Part A.

[22]  J. Hopper,et al.  Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis , 2015, Expert Reviews in Molecular Medicine.

[23]  M. Bellgrove,et al.  Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women , 2015, Neurology.

[24]  Tom R. Gaunt,et al.  Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children , 2015, International journal of epidemiology.

[25]  Tom R. Gaunt,et al.  The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019 , 2019, Wellcome open research.

[26]  R. Eiges,et al.  FMR1 Epigenetic Silencing Commonly Occurs in Undifferentiated Fragile X-Affected Embryonic Stem Cells , 2014, Stem cell reports.

[27]  D. Loesch,et al.  Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. , 2014, Clinical chemistry.

[28]  M. Disney,et al.  Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome , 2014, Science.

[29]  P. Hagerman,et al.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome , 2013, The Lancet Neurology.

[30]  E. Lyon,et al.  ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics , 2013, Genetics in Medicine.

[31]  D. Loesch,et al.  Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty. , 2013, Human molecular genetics.

[32]  J. Boyle,et al.  Maternal attitudes to newborn screening for fragile X syndrome , 2013, American journal of medical genetics. Part A.

[33]  D. Loesch,et al.  Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study , 2012, Genetics in Medicine.

[34]  G. Satten,et al.  Age-associated DNA methylation in pediatric populations. , 2012, Genome research.

[35]  D. Loesch,et al.  Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. , 2012, Clinical chemistry.

[36]  D. Loesch,et al.  FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. , 2011, The Journal of molecular diagnostics : JMD.

[37]  P. Hagerman,et al.  Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome , 2011, PloS one.

[38]  Bernhard Korn,et al.  Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. , 2011, American journal of human genetics.

[39]  Клинические дисциплины.  Autism Diagnostic Observation Schedule , 2010 .

[40]  D. Loesch,et al.  Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. , 2010, Human molecular genetics.

[41]  L. Zwaigenbaum,et al.  Paternal transmission of fragile X syndrome , 2004, American journal of medical genetics. Part A.

[42]  C. Mathew,et al.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. , 1994, American journal of human genetics.

[43]  K. A. Lang,et al.  Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. , 1994, JAMA.

[44]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[45]  J. Mandel,et al.  Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. , 1991, Journal of medical genetics.

[46]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.